USPTO serial 87822368
CULMINATION
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Apr 5, 2022
- Examiner
- O'ROURKE, JONATHAN RYAN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with CULMINATION?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Salt Lake City, UT
Salt Lake City, UT
Salt Lake City, UT
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Joshua G. Gigger
Joshua G. Gigger STOEL RIVES LLP201 SOUTH MAIN STREET, SUITE 1100SALT LAKE CITY, UT 84111UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Medical research and analysis services, namely, medical laboratory research and medical laboratory services; biological research and analysis services; genetic analysis services in the nature of genetic testing for scientific research purposes; cell, cell line, tissue, tissue line and bodily fluid analysis services in the nature of medical laboratory research for scientific research purposes; scientific laboratory services in the fields of medical, health and biological data analysis; scientific research and analysis in the fields of bioinformatics, biomarkers, genomics, proteomics, genotyping, and genetic profiling; providing medical research and scientific research information in the fields of pathology, pharmacology, immunology, bioinformatics, biomarkers, genomics, proteomics, genotyping, and genetic profiling; preparation of biological samples for research purposes; medical laboratory services; medical and scientific laboratory services for collecting, incubating, growing, controlling, processing, analyzing, transporting and storing biological samples; operating and maintaining a biorepository for medical and scientific research purposes; laboratory services, namely, isolation, archival storage and chain-of-custody management of DNA, RNA, cells, cell lines, tissue, tissue lines, formalin-fixed paraffin-embedded tissue, and bodily fluid specimens for others; consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenomics; research and development services in the nature of creating libraries and collections of DNA, RNA, cells, cell lines, tissue, tissue lines, formalin-fixed paraffin-embedded tissue, and bodily fluid specimens; computer modeling services; and computer simulation based on computer programs for others; providing online non-downloadable software for the collection, storage, management, organization, analysis, and display of data in the fields of bioinformatics, biomarkers, genomics, proteomics, genotyping, and genetic profiling for medical diagnostic and treatment research purposes; software as a service services featuring software for the collection, storage, management, organization, analysis, and display of data in the fields of bioinformatics, biomarkers, genomics, proteomics, genotyping, and genetic profiling for medical diagnostic and treatment research purposes; providing an online computer database for medical and scientific researchers in the fields of bioinformatics, biomarkers, genomics, proteomics, genotyping, and genetic profiling; and development of computer software and hardware for use in medical, health and biological data analysis; analyzing and compiling data for research purposes in the field of medical science and medical consultancy; and compilation, systemization and administration of medical, health and biological data for research purposes via computer apparatus and computer databases | ACTIVE | Feb 17, 2022 |
| 044 | Gene and human tissue bank services in the nature of biological asset bank repository services for DNA, RNA, cells, cell lines, tissue, tissue lines, formalin-fixed paraffin-embedded tissue, and bodily fluid specimens; isolation, collection, preservation and banking of biological assets, namely, DNA, RNA, cells, cell lines, tissue, tissue lines, formalin-fixed paraffin-embedded tissue, and bodily fluid specimens; collection, organization, analysis, and reporting of medical data in connection with clinical and non-clinical trials and studies on pharmaceuticals and medical devices; medical analysis of biological assets, namely, DNA, RNA, cells, cell lines, tissue, tissue lines, formalin-fixed paraffin-embedded tissue, and bodily fluid specimens, for medical diagnostic and treatment purposes; providing a website featuring medical information in the fields of bioinformatics, biomarkers, genomics, proteomics, genotyping, and genetic profiling; providing online non-downloadable searchable databases and non-searchable databases featuring medical information in the fields of bioinformatics, biomarkers, genomics, proteomics, genotyping, and genetic profiling; providing medical information in the fields of bioinformatics, biomarkers, genomics, proteomics, genotyping, and genetic profiling; genetic analysis services in the nature of genetic testing for medical purposes; and cell, cell line, tissue, tissue line and bodily fluid analysis services in the nature of genetic testing for medical purposes | ACTIVE | Feb 17, 2022 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Culmination, Inc.
- Other trademarks owned by Culmination, Inc.
- Other trademarks owned by Culmination, Inc.
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named CULMINATION
- Prosecution event R.PR explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 5, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 3, 2022 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Mar 2, 2022 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Mar 1, 2022 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Feb 27, 2022 | IUAF | USE AMENDMENT FILED | — |
| Feb 27, 2022 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Aug 27, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 26, 2021 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Aug 26, 2021 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Aug 24, 2021 | EXT5 | SOU EXTENSION 5 FILED | — |
| Aug 24, 2021 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 27, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Feb 25, 2021 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Feb 25, 2021 | EXT4 | SOU EXTENSION 4 FILED | — |
| Feb 25, 2021 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Aug 25, 2020 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 21, 2020 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Aug 21, 2020 | EXT3 | SOU EXTENSION 3 FILED | — |
| Aug 21, 2020 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 26, 2020 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Feb 24, 2020 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Feb 24, 2020 | EXT2 | SOU EXTENSION 2 FILED | — |
| Feb 24, 2020 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 24, 2020 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Feb 24, 2020 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Feb 24, 2020 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 24, 2020 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Feb 24, 2020 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jul 4, 2019 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 2, 2019 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 2, 2019 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jul 2, 2019 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jul 2, 2019 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 26, 2019 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jan 1, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 1, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 12, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 26, 2018 | ALIE | ASSIGNED TO LIE | — |
| Nov 6, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 6, 2018 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Nov 6, 2018 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Nov 6, 2018 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Nov 6, 2018 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Nov 5, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 4, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 4, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 28, 2018 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 28, 2018 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 28, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 18, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 13, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 9, 2018 | NWAP | NEW APPLICATION ENTERED | — |